Short stature, new treatment, Rush University Medical Center
Tue, 20 Sep 2005 11:00 PM EST
... Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure. The drug, called Increlex, was approved by the FDA August 31 for the most severe form of short stature due to a deficiency of Insulin-like Growth Factor-1 (IGF-1)... click link for more info. ...
Related Topics
- Understanding Medical Research
- Medical Education & Training
- Medical Care
- Centers Of Excellence
- Drug and Medical Device Safety
- Integrative medicine
- Medical Errors
- Emergency Medical Services
- Complementary medicine
- Toxoplasmosis
- Visitors Center
- Horsetail
- Diagnosis
- Birth Centers
- Short Bowel Syndrome
- Treatment
- Treatments
- Acute Care
- Substance Abuse
- Frostbite

Not Signed In -


